Twist1 is not only involved in the development of acquired drug resistance in human cancer cells but is also associated with chemotherapy resistance when overexpressed, leading to a poorer prognosis (Lu et al. 2014; Deng et al. 2016; Liu et al. 2017). Here, TWIST1 is linked to cancer.